1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Bladder cancer

Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy

Technology appraisal guidance [TA519] Published date: 25 April 2018

  • Guidance
  • Tools and resources
  • Information for the public
  • History

Documents

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 232.65 KB 25 April 2018  

Final appraisal determination

  • Final appraisal determination  
  • Final appraisal determination document PDF 401.22 KB 16 March 2018  
  • Public committee slides PDF 492.18 KB 16 March 2018  
  • Committee papers - Managed Access Agreement PDF 481.74 KB 16 March 2018  
  • Committee papers PDF 3.83 MB 16 March 2018  

Appraisal consultation

  • Appraisal consultation  
  • Appraisal consultation document PDF 359.63 KB 03 August 2017  
  • Committee papers PDF 29.98 MB 03 August 2017  
  • Public committee slides PDF 746.32 KB 03 August 2017  
  • Public committee slides PDF 796.95 KB 03 August 2017  

Invitation to participate

  • Final scope PDF 226.25 KB 15 December 2016  
  • Final matrix PDF 259.67 KB 15 December 2016  
  • NICE's response to comments on the draft scope and provisional matrix PDF 288.73 KB 15 December 2016  
  • Equality impact assessment (Scoping) PDF 170.9 KB 15 December 2016